Firestone Capital Management Amgen Inc Transaction History

Firestone Capital Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$255.7 - $288.46 $1,534 - $1,730	6 Added 0.57%	1,051 $302,000
Q3 2023 Nov 06, 2023	BUY	$218.65 - $271.46 $1,311 - $1,628	6 Added 0.58%	1,045 $280,000
Q2 2023 Jul 26, 2023	BUY	$214.27 - $253.37 $1,499 - $1,773	7 Added 0.68%	1,039 $230,000
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $57,802 - $70,451	256 Added 32.99%	1,032 $249,000
Q4 2022 Feb 09, 2023	BUY	$229.03 - $291.01 $177,727 - $225,823	776 New	776 $203,000
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $15,114 - $17,297	-76 Closed	0 $0
Q1 2021 Apr 28, 2021	SELL	$221.91 - $258.6 $443 - $517	-2 Reduced 2.56%	76 $19,000
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $372,743 - $479,104	-1,970 Reduced 96.19%	78 $19,000
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $387,502 - $498,073	2,048 New	2,048 $19,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Firestone Capital Management, based on Form 13F filings with the SEC.

Stay updated on Firestone Capital Management with notifications on news.